全文获取类型
收费全文 | 4817篇 |
免费 | 298篇 |
国内免费 | 22篇 |
专业分类
耳鼻咽喉 | 96篇 |
儿科学 | 249篇 |
妇产科学 | 32篇 |
基础医学 | 366篇 |
口腔科学 | 76篇 |
临床医学 | 398篇 |
内科学 | 1339篇 |
皮肤病学 | 53篇 |
神经病学 | 361篇 |
特种医学 | 156篇 |
外科学 | 891篇 |
综合类 | 100篇 |
一般理论 | 1篇 |
预防医学 | 163篇 |
眼科学 | 238篇 |
药学 | 340篇 |
中国医学 | 11篇 |
肿瘤学 | 267篇 |
出版年
2023年 | 57篇 |
2022年 | 99篇 |
2021年 | 236篇 |
2020年 | 86篇 |
2019年 | 151篇 |
2018年 | 225篇 |
2017年 | 131篇 |
2016年 | 146篇 |
2015年 | 131篇 |
2014年 | 231篇 |
2013年 | 307篇 |
2012年 | 425篇 |
2011年 | 429篇 |
2010年 | 223篇 |
2009年 | 165篇 |
2008年 | 280篇 |
2007年 | 316篇 |
2006年 | 296篇 |
2005年 | 244篇 |
2004年 | 195篇 |
2003年 | 163篇 |
2002年 | 147篇 |
2001年 | 39篇 |
2000年 | 47篇 |
1999年 | 41篇 |
1998年 | 20篇 |
1997年 | 16篇 |
1996年 | 11篇 |
1995年 | 19篇 |
1994年 | 10篇 |
1993年 | 8篇 |
1992年 | 21篇 |
1991年 | 21篇 |
1990年 | 16篇 |
1989年 | 14篇 |
1988年 | 15篇 |
1987年 | 16篇 |
1986年 | 6篇 |
1985年 | 16篇 |
1984年 | 13篇 |
1983年 | 8篇 |
1979年 | 8篇 |
1977年 | 4篇 |
1975年 | 5篇 |
1974年 | 8篇 |
1973年 | 4篇 |
1972年 | 11篇 |
1971年 | 13篇 |
1970年 | 10篇 |
1968年 | 4篇 |
排序方式: 共有5137条查询结果,搜索用时 31 毫秒
71.
72.
The rapid introduction of Internet of Things (IoT) Technology has boosted the service deliverance aspects of health sector in terms of m-health, and remote patient monitoring. IoT Technology is not only capable of sensing the acute details of sensitive events from wider perspectives, but it also provides a means to deliver services in time sensitive and efficient manner. Henceforth, IoT Technology has been efficiently adopted in different fields of the healthcare domain. In this paper, a framework for IoT based patient monitoring in Intensive Care Unit (ICU) is presented to enhance the deliverance of curative services. Though ICUs remained a center of attraction for high quality care among researchers, still number of studies have depicted the vulnerability to a patient’s life during ICU stay. The work presented in this study addresses such concerns in terms of efficient monitoring of various events (and anomalies) with temporal associations, followed by time sensitive alert generation procedure. In order to validate the system, it was deployed in 3 ICU room facilities for 30 days in which nearly 81 patients were monitored during their ICU stay. The results obtained after implementation depicts that IoT equipped ICUs are more efficient in monitoring sensitive events as compared to manual monitoring and traditional Tele-ICU monitoring. Moreover, the adopted methodology for alert generation with information presentation further enhances the utility of the system. 相似文献
73.
Sharmistha Chakraborty Li Li Hao Tang Yang Xie Vineshkumar Thidil Puliyappadamba Jack Raisanen Sandeep Burma David A Boothman Brent Cochran Julian Wu Amyn A Habib 《Neoplasia (New York, N.Y.)》2013,15(8):888-897
Tumor necrosis factor receptor 1 (TNFR1)-associated death domain protein (TRADD) is an important adaptor in TNFR1 signaling and has an essential role in nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) activation and survival signaling. Increased expression of TRADD is sufficient to activate NF-κB. Recent studies have highlighted the importance of NF-κB activation as a key pathogenic mechanism in glioblastoma multiforme (GBM), the most common primary malignant brain tumor in adults.We examined the expression of TRADD by immunohistochemistry (IHC) and find that TRADD is commonly expressed at high levels in GBM and is detected in both cytoplasmic and nuclear distribution. Cytoplasmic IHC TRADD scoring is significantly associated with worse progression-free survival (PFS) both in univariate and multivariate analysis but is not associated with overall survival (n = 43 GBMs). PFS is a marker for responsiveness to treatment. We propose that TRADD-mediated NF-κB activation confers chemoresistance and thus a worse PFS in GBM. Consistent with the effect on PFS, silencing TRADD in glioma cells results in decreased NF-κB activity, decreased proliferation of cells, and increased sensitivity to temozolomide. TRADD expression is common in glioma-initiating cells. Importantly, silencing TRADD in GBM-initiating stem cell cultures results in decreased viability of stem cells, suggesting that TRADD may be required for maintenance of GBM stem cell populations. Thus, our study suggests that increased expression of cytoplasmic TRADD is both an important biomarker and a key driver of NF-κB activation in GBM and supports an oncogenic role for TRADD in GBM. 相似文献
74.
75.
76.
77.
11Beta-hydroxysteroid dehydrogenase inhibition improves cognitive function in healthy elderly men and type 2 diabetics 总被引:3,自引:0,他引:3 下载免费PDF全文
Sandeep TC Yau JL MacLullich AM Noble J Deary IJ Walker BR Seckl JR 《Proceedings of the National Academy of Sciences of the United States of America》2004,101(17):6734-6739
In aging humans and rodents, inter-individual differences in cognitive function have been ascribed to variations in long-term glucocorticoid exposure. 11beta-Hydroxysteroid dehydrogenase type 1 (11beta-HSD1) regenerates the active glucocorticoid cortisol from circulating inert cortisone, thus amplifying intracellular glucocorticoid levels in some tissues. We show that 11beta-HSD1, but not 11beta-HSD2, mRNA is expressed in the human hippocampus, frontal cortex, and cerebellum. In two randomized, double-blind, placebo-controlled crossover studies, administration of the 11beta-HSD inhibitor carbenoxolone (100 mg three times per day) improved verbal fluency (P < 0.01) after 4 weeks in 10 healthy elderly men (aged 55-75 y) and improved verbal memory (P < 0.01) after 6 weeks in 12 patients with type 2 diabetes (52-70 y). Although carbenoxolone has been reported to enhance hepatic insulin sensitivity in short-term studies, there were no changes in glycemic control or serum lipid profile, nor was plasma cortisol altered. 11beta-HSD1 inhibition may be a new approach to prevent/ameliorate cognitive decline. 相似文献
78.
Does aggressive statin therapy offer improved cholesterol-independent benefits compared to conventional statin treatment? 总被引:4,自引:0,他引:4
Gupta S 《International journal of cardiology》2004,96(2):131-139
There is currently intense research interest in the properties of HMG-CoA reductase inhibitors (statins) beyond their well-documented lipid-lowering action. Studies have consistently demonstrated that administration of statin therapy decreases levels of the inflammatory marker C-reactive protein (CRP), a marker associated with an increased risk of cardiovascular events. This effect appears to be independent of the extent of reduction in total or LDL-cholesterol. Statins also appear to improve endothelial dysfunction by increasing endothelium-dependent vasodilatation. There is also evidence that statins inhibit fibrin formation and thrombus development, an effect that which would be clinically beneficial following plaque fissure or rupture. Early preclinical and clinical evidence suggests that there are quantitative differences between statin regimens in terms of their cholesterol-independent properties. Trials comparing equipotent doses of different statins, based on lipid-lowering efficacy, have not reported any differences in cholesterol-independent properties. However, the current evidence base indicates that more aggressive statin regimens are associated with an enhanced anti-inflammatory effect. Intensive lipid-lowering using statin therapy generates a greater reduction in mortality than standard lipid management, and it is possible that enhanced cholesterol-independent effects may account for some of this excess benefit. 相似文献
79.
80.